Abnormal mTOR Activity in Pediatric Autoimmune Neuropsychiatric and MIA-Associated Autism Spectrum Disorders.
Ekaterina A TrifonovaZakhar S MustafinSergey A LashinAlex V KochetovPublished in: International journal of molecular sciences (2022)
Autism spectrum disorder (ASD) is a neurodevelopmental condition characterized by the early onset of communication and behavioral problems. ASD is highly heritable; however, environmental factors also play a considerable role in this disorder. A significant part of both syndromic and idiopathic autism cases could be attributed to disorders caused by mammalian target of rapamycin (mTOR)-dependent translation deregulation. This narrative review analyzes both bioinformatic and experimental evidence that connects mTOR signaling to the maternal autoantibody-related (MAR) autism spectrum and autoimmune neuropsychiatric disorders simultaneously. In addition, we reconstruct a network presenting the interactions between the mTOR signaling and eight MAR ASD genes coding for ASD-specific maternal autoantibody target proteins. The research discussed in this review demonstrates novel perspectives and validates the need for a subtyping of ASD on the grounds of pathogenic mechanisms. The utter necessity of designing ELISA-based test panels to identify all antibodies related to autism-like behavior is also considered.
Keyphrases
- autism spectrum disorder
- intellectual disability
- early onset
- attention deficit hyperactivity disorder
- cell proliferation
- multiple sclerosis
- late onset
- mental health
- birth weight
- drug induced
- genome wide
- gene expression
- case report
- body mass index
- young adults
- transcription factor
- congenital heart disease
- weight gain